Is telehealth allowed to prescribe Wellbutrin in Pennsylvania?

Binge Eating Disorder (BED) affects millions of Americans, yet many struggle to access appropriate treatment due to provider shortages, stigma, or geographic barriers. Telehealth has emerged as a viable solution, especially for non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion) that can help manage BED symptoms. But with telehealth regulations constantly evolving, patients often wonder: ‘Can I actually get these medications online, and what rules apply?’

This comprehensive guide explores the current telehealth landscape for BED treatment as of early 2026, clarifying the rules around prescribing, state-specific considerations, and what to expect from a legitimate telehealth experience.

Understanding Telehealth Medication Rules: The Basics

Federal vs. State Regulations

When it comes to telehealth prescribing, it’s crucial to understand that different rules apply to controlled versus non-controlled medications:

• Non-controlled medications (including Topamax and Wellbutrin for BED) can be prescribed via telehealth in all 50 states without an in-person visit requirement under federal law. These medications were never subject to the Ryan Haight Act restrictions that affect controlled substances.

• Controlled substances (like Vyvanse, the only FDA-approved medication for BED) face stricter regulation. While emergency flexibilities currently allow telehealth prescribing of controlled medications through December 31, 2026, permanent rules are still being finalized.

Klarity Health’s licensed providers keep up-to-date with these regulations to ensure patients can access appropriate BED treatment options within the legal framework, focusing particularly on effective non-controlled medication options.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules for BED Medications

While federal law permits telehealth prescribing of non-controlled medications like Topamax and Wellbutrin, some states have additional requirements. Here’s what you need to know about key states:

States with No In-Person Requirement

Most states, including California, Delaware, New York, and Michigan, allow fully remote prescribing of non-controlled medications without requiring any in-person visits. In these states, a telehealth evaluation is considered legally equivalent to an in-person exam.

For example, California specifically defines a ‘good faith exam’ to include asynchronous telehealth, maximizing flexibility for patients seeking BED treatment.

States with Periodic In-Person Requirements

A few states maintain requirements for periodic in-person follow-ups when using telehealth long-term:

• Alabama: If you’ve had more than 4 telehealth visits in 12 months for the same condition, you must have an in-person exam within a year
• Georgia: Requires an annual attempt at in-person follow-up for ongoing telehealth care
• New Hampshire: Requires an in-person exam at least every 12 months for continued prescribing

Even in these states, the initial evaluation and prescription can typically be done entirely via telehealth, with the in-person requirement applying only to ongoing care. Additionally, this in-person visit can often be satisfied by any collaborating provider in the practice, not necessarily the original prescriber.

Who Can Prescribe BED Medications via Telehealth?

Nurse Practitioners and Physician Assistants

The ability of non-physician providers to prescribe BED medications varies by state:

• Full Practice Authority States: In approximately 34 states and DC, Nurse Practitioners have independent prescribing authority, meaning they can evaluate patients and prescribe non-controlled medications without physician oversight. Recent additions to this list include Wisconsin, Michigan, and Kansas.

• Collaborative Agreement States: In states like Florida, Texas, and Georgia, NPs/PAs must work under a formal agreement with a physician to prescribe medications. This doesn’t typically affect the patient experience but is a behind-the-scenes regulatory requirement.

At Klarity Health, we work with licensed providers who understand their state’s scope of practice, ensuring that all prescriptions are issued appropriately and legally, whether through MDs, DOs, NPs, or PAs.

The Telehealth Prescribing Process for BED

Patient Eligibility Assessment

To receive medication for BED via telehealth, you’ll need to meet the clinical criteria for Binge Eating Disorder. Providers will conduct a thorough evaluation that typically includes:

• Assessment of your eating behaviors, particularly episodes of eating an abnormally large amount within a discrete time period (usually within 2 hours)
• Evaluation of feelings of loss of control during these episodes
• Confirmation that these episodes occur at least once weekly for 3 months (per DSM-5 criteria)
• Screening for other eating disorders like anorexia or bulimia, which would affect treatment recommendations

The provider will document that you meet DSM-5 criteria for BED, obtain informed consent for telehealth treatment, and create a comprehensive medical record of your evaluation.

Medication Options and Considerations

Two commonly prescribed non-controlled medications for BED include:

1. Topiramate (Topamax)

• Used off-label for BED (FDA-approved for seizures and migraines)
• Typically started at a low dose and gradually increased
• Not recommended during pregnancy due to birth defect risks
• Requires monitoring for cognitive side effects and weight changes

1. Bupropion (Wellbutrin)

• Used off-label for BED (FDA-approved for depression and smoking cessation)
• Contraindicated in patients with a history of seizures, anorexia, or bulimia
• Carries a black box warning about increased risk of suicidal thoughts in young adults
• Requires monitoring for blood pressure changes and mood effects

These medications are used ‘off-label’ for BED, which is a legal and common medical practice. Your provider should clearly explain this, along with the risks and benefits, before prescribing.

Who Is Not a Good Candidate for Telehealth BED Treatment?

Safety is paramount in telehealth. Providers will screen for conditions that might make you unsuitable for online treatment with these medications:

• History of anorexia or bulimia (contraindication for bupropion)
• Uncontrolled seizure disorders (caution with both medications)
• Pregnancy or planning pregnancy (topiramate can cause birth defects)
• Severe medical instability requiring in-person evaluation
• Need for controlled medications that face stricter telehealth regulations

Reputable telehealth providers, including those at Klarity Health, prioritize patient safety and will refer you to in-person care when appropriate.

Ensuring Quality and Safety in Telehealth BED Treatment

Red Flags to Watch For

As telehealth has grown, so has scrutiny of online prescribing practices. Legitimate telehealth services implement strict protocols to ensure quality care:

• Thorough evaluations (typically 30+ minutes for an initial BED consultation)
• Identity and location verification
• Comprehensive medical history collection
• Discussion of multiple treatment options, not just medication
• Appropriate starting doses with careful titration
• Regular follow-up appointments to monitor progress
• Prescriptions sent to legitimate pharmacies, not shipped directly from the service

Beware of services that promise medications before evaluation or skip over discussing therapy options, as medication is just one component of comprehensive BED treatment.

Follow-Up and Monitoring

Unlike controlled substances that may require monthly prescriptions, providers can often give refills for non-controlled BED medications like Topamax or Wellbutrin. However, expect regular follow-up appointments, especially when starting treatment:

• Initial evaluation
• 2-week or 1-month check-in to assess medication tolerance
• Monthly or bimonthly follow-ups to monitor progress
• Annual comprehensive review (required in some states)

Klarity Health’s approach emphasizes consistent follow-up care, ensuring that patients receive ongoing support throughout their treatment journey.

Recent Developments in Telehealth Regulations (2025-2026)

The regulatory landscape continues to evolve, with several notable developments:

• In late 2025, the DEA extended pandemic-era flexibilities for controlled substance telehealth prescribing through December 31, 2026
• Several states refined their telehealth laws, generally moving toward greater access
• New Hampshire removed barriers to telehealth prescribing for many medications
• New York implemented rules requiring in-person visits for new controlled substance prescriptions (but not for non-controlled medications)
• More states granted full practice authority to nurse practitioners, expanding the pool of available telehealth providers

These changes generally maintain or expand telehealth access for non-controlled BED medications while implementing targeted safety measures for controlled substances.

Conclusion: Telehealth as a Viable Option for BED Treatment

Telehealth remains a legal, accessible, and effective way to receive evaluation and treatment for

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12